The U.S. Food and Drug Administration has approved Trogarzo (ibalizumab), the first HIV-1 inhibitor for patients with multi-drug resistant HIV-1. Source: BioSpace

Seattle Genetics dosed its first patient with an early-stage treatment for patients with relapsed or refractory multiple myeloma (MM). Source: BioSpace

The U.S. Food and Drug Administration (FDA) approved the first-ever direct-to-consumer genetic test for cancer risk. Source: BioSpace

Giuseppe Ciaramella, formerly chief scientific officer of Moderna Therapeutics’ Valera unit, has left for an unidentified stealth-mode biotech startup. Source: BioSpace

Job seekers typically focus on three things: the resume, the cover letter, and how to answer interview questions. But many candidates don't realize how important it is to have well-researched,…

Magenta Therapeutics is teaming up with Ladenburg, Germany-based Heidelberg Pharma to improve curative bone marrow transplantation. Source: BioSpace

Days before his sentencing for a criminal fraud conviction disgraced pharma entrepreneur Martin Shkreli has been ordered to forfeit $7.36 million. Source: BioSpace

The American College of Physicians suggested that some patients with type 2 diabetes can allow their blood-sugar levels to remain above those ideal targets that have been standard of practice.…

The U.S. Food and Drug Administration (FDA) expanded the dosing schedule for Bristol-Myers Squibb’s Opdivo (nivolumab). Source: BioSpace

After 35 years at the helm of Parexel International Corporation, co-founder Josef von Rickenbach is stepping down from his role as chief executive officer. Source: BioSpace